Melanoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Real-world Evaluation of the Impact of Baseline Metastases on Clinical Outcomes Among BRAF Positive Metastatic Melanoma Patients
Condition:   BRAF Positive Metastatic Melanoma Intervention:   Sponsor:   Novartis Pharmaceuticals Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2023 Category: Research Source Type: clinical trials

Fluzoparib in Combination With Camrelizumab and Temozolomide in Advanced Melanoma
Condition:   Melanoma Intervention:   Drug: Fluzoparib Camrelizumab Temozolomide Sponsor:   Jun Guo Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2023 Category: Research Source Type: clinical trials

Clinical, Radiological, Histologic and Molecular Features of a Cohort of Melanocytic Tumors of the Central Nervous System
Conditions:   Meningeal Melanocytoma;   Meningeal Melanomatosis;   Meningeal Melanocytosis;   Meningeal Melanoma Intervention:   Sponsor:   Central Hospital, Nancy, France Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2023 Category: Research Source Type: clinical trials

Fluzoparib in Combination With Camrelizumab and Temozolomide in Advanced Melanoma
Condition:   Melanoma Intervention:   Drug: Fluzoparib Camrelizumab Temozolomide Sponsor:   Jun Guo Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2023 Category: Research Source Type: clinical trials

Clinical, Radiological, Histologic and Molecular Features of a Cohort of Melanocytic Tumors of the Central Nervous System
Conditions:   Meningeal Melanocytoma;   Meningeal Melanomatosis;   Meningeal Melanocytosis;   Meningeal Melanoma Intervention:   Sponsor:   Central Hospital, Nancy, France Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2023 Category: Research Source Type: clinical trials

Real-world Evaluation of the Impact of Baseline Metastases on Clinical Outcomes Among BRAF Positive Metastatic Melanoma Patients
Condition:   BRAF Positive Metastatic Melanoma Intervention:   Sponsor:   Novartis Pharmaceuticals Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2023 Category: Research Source Type: clinical trials

Clinical, Radiological, Histologic and Molecular Features of a Cohort of Melanocytic Tumors of the Central Nervous System
Conditions:   Meningeal Melanocytoma;   Meningeal Melanomatosis;   Meningeal Melanocytosis;   Meningeal Melanoma Intervention:   Sponsor:   Central Hospital, Nancy, France Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2023 Category: Research Source Type: clinical trials

Fluzoparib in Combination With Camrelizumab and Temozolomide in Advanced Melanoma
Condition:   Melanoma Intervention:   Drug: Fluzoparib Camrelizumab Temozolomide Sponsor:   Jun Guo Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2023 Category: Research Source Type: clinical trials

Real-world Evaluation of the Impact of Baseline Metastases on Clinical Outcomes Among BRAF Positive Metastatic Melanoma Patients
Condition:   BRAF Positive Metastatic Melanoma Intervention:   Sponsor:   Novartis Pharmaceuticals Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2023 Category: Research Source Type: clinical trials

Clinical, Radiological, Histologic and Molecular Features of a Cohort of Melanocytic Tumors of the Central Nervous System
Conditions:   Meningeal Melanocytoma;   Meningeal Melanomatosis;   Meningeal Melanocytosis;   Meningeal Melanoma Intervention:   Sponsor:   Central Hospital, Nancy, France Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2023 Category: Research Source Type: clinical trials

Fluzoparib in Combination With Camrelizumab and Temozolomide in Advanced Melanoma
Condition:   Melanoma Intervention:   Drug: Fluzoparib Camrelizumab Temozolomide Sponsor:   Peking University Cancer Hospital & Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2023 Category: Research Source Type: clinical trials

Real-world Evaluation of the Impact of Baseline Metastases on Clinical Outcomes Among BRAF Positive Metastatic Melanoma Patients
Condition:   BRAF Positive Metastatic Melanoma Intervention:   Sponsor:   Novartis Pharmaceuticals Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2023 Category: Research Source Type: clinical trials

Clinical, Radiological, Histologic and Molecular Features of a Cohort of Melanocytic Tumors of the Central Nervous System
Conditions:   Meningeal Melanocytoma;   Meningeal Melanomatosis;   Meningeal Melanocytosis;   Meningeal Melanoma Intervention:   Sponsor:   Central Hospital, Nancy, France Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2023 Category: Research Source Type: clinical trials